Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanny Yeshua

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Seminars in Cardiothoracic and Vascular Anesthesia|April 2, 2009
Pulmonary manifestations of liver diseasesHanny Yeshua, Laurie M Blendis, Ran Oren
European Journal of Preventive Cardiology|March 9, 2018
Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohortYochai Schonmann, Oz Bleich, Andre Matalon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 20, 2025
Response Letter to: Expanding Perspectives on FIB-4 as a Predictor of Hepatic and Extrahepatic Malignancy RiskShira Zelber-Sagi, Yochai Schonmann, Galit Weinstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 1, 2024
The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort studyGalit Weinstein, Yochai Schonmann, Hanny Yeshua, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2025
Liver Fibrosis Marker FIB-4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population-Based Cohort StudyShira Zelber-Sagi, Yochai Schonmann, Galit Weinstein, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 29, 2021
Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?"Shira Zelber-Sagi, Yochai Schonmann, Hanny Yeshua, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2020
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general populationYochai Schonmann, Hanny Yeshua, Itay Bentov, et al.
Family Practice|September 6, 2018
Comparison of antidepressant use between adult populations living in urban and rural communities in IsraelSharon Leventhal Perek, Katharine Thomas, Anat Gaver, et al.
AJR. American Journal of Roentgenology|March 24, 2009
Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosisMuriel Webb, Hanny Yeshua, Shira Zelber-Sagi, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 6, 2013
Retinal blood flow velocity in metabolic syndromeShay Gutfreund, Elena Izkhakov, Russell Pokroy, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Seminars in Cardiothoracic and Vascular Anesthesia|April 2, 2009
Pulmonary manifestations of liver diseasesHanny Yeshua, Laurie M Blendis, Ran Oren
European Journal of Preventive Cardiology|March 9, 2018
Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohortYochai Schonmann, Oz Bleich, Andre Matalon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 20, 2025
Response Letter to: Expanding Perspectives on FIB-4 as a Predictor of Hepatic and Extrahepatic Malignancy RiskShira Zelber-Sagi, Yochai Schonmann, Galit Weinstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 1, 2024
The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort studyGalit Weinstein, Yochai Schonmann, Hanny Yeshua, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 13, 2025
Liver Fibrosis Marker FIB-4 Is Associated With Hepatic and Extrahepatic Malignancy Risk in a Population-Based Cohort StudyShira Zelber-Sagi, Yochai Schonmann, Galit Weinstein, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 29, 2021
Reply to: "Assessment of hepatic fibrosis in MAFLD: a new player in the evaluation of residual cardiovascular risk?"Shira Zelber-Sagi, Yochai Schonmann, Hanny Yeshua, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2020
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general populationYochai Schonmann, Hanny Yeshua, Itay Bentov, et al.
Family Practice|September 6, 2018
Comparison of antidepressant use between adult populations living in urban and rural communities in IsraelSharon Leventhal Perek, Katharine Thomas, Anat Gaver, et al.
AJR. American Journal of Roentgenology|March 24, 2009
Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosisMuriel Webb, Hanny Yeshua, Shira Zelber-Sagi, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|April 6, 2013
Retinal blood flow velocity in metabolic syndromeShay Gutfreund, Elena Izkhakov, Russell Pokroy, et al.
Pageof 2